These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10817746)
41. Haploidy, diploidy and evolution of antifungal drug resistance in Saccharomyces cerevisiae. Anderson JB; Sirjusingh C; Ricker N Genetics; 2004 Dec; 168(4):1915-23. PubMed ID: 15371350 [TBL] [Abstract][Full Text] [Related]
42. Fluconazole inhibits cellular ergosterol synthesis to confer synergism with berberine against yeast cells. Yang Z; Wang Q; Ma K; Shi P; Liu W; Huang Z J Glob Antimicrob Resist; 2018 Jun; 13():125-130. PubMed ID: 29287714 [TBL] [Abstract][Full Text] [Related]
43. Genetic prerequisites for additive or synergistic actions of 5-fluorocytosine and fluconazole in baker's yeast. Paluszynski JP; Klassen R; Meinhardt F Microbiology (Reading); 2008 Oct; 154(Pt 10):3154-3164. PubMed ID: 18832321 [TBL] [Abstract][Full Text] [Related]
44. Requirement of one functional RAS gene and inability of an oncogenic ras variant to mediate the glucose-induced cyclic AMP signal in the yeast Saccharomyces cerevisiae. Mbonyi K; Beullens M; Detremerie K; Geerts L; Thevelein JM Mol Cell Biol; 1988 Aug; 8(8):3051-7. PubMed ID: 2850478 [TBL] [Abstract][Full Text] [Related]
45. Activation state of the Ras2 protein and glucose-induced signaling in Saccharomyces cerevisiae. Colombo S; Ronchetti D; Thevelein JM; Winderickx J; Martegani E J Biol Chem; 2004 Nov; 279(45):46715-22. PubMed ID: 15339905 [TBL] [Abstract][Full Text] [Related]
46. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae. Coste AT; Ramsdale M; Ischer F; Sanglard D Microbiology (Reading); 2008 May; 154(Pt 5):1491-1501. PubMed ID: 18451058 [TBL] [Abstract][Full Text] [Related]
47. Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14α-Demethylase. Sagatova AA; Keniya MV; Wilson RK; Monk BC; Tyndall JD Antimicrob Agents Chemother; 2015 Aug; 59(8):4982-9. PubMed ID: 26055382 [TBL] [Abstract][Full Text] [Related]
48. The high-affinity cAMP phosphodiesterase of Saccharomyces cerevisiae is the major determinant of cAMP levels in stationary phase: involvement of different branches of the Ras-cyclic AMP pathway in stress responses. Park JI; Grant CM; Dawes IW Biochem Biophys Res Commun; 2005 Feb; 327(1):311-9. PubMed ID: 15629464 [TBL] [Abstract][Full Text] [Related]
49. Metabolic control analysis and engineering of the yeast sterol biosynthetic pathway. Groeneveld P; Rolley N; Kell DB; Kelly SL; Kelly DE Mol Biol Rep; 2002; 29(1-2):27-9. PubMed ID: 12241069 [No Abstract] [Full Text] [Related]
50. FLR1 gene (ORF YBR008c) is required for benomyl and methotrexate resistance in Saccharomyces cerevisiae and its benomyl-induced expression is dependent on pdr3 transcriptional regulator. Brôco N; Tenreiro S; Viegas CA; Sá-Correia I Yeast; 1999 Nov; 15(15):1595-608. PubMed ID: 10572257 [TBL] [Abstract][Full Text] [Related]
51. Anethole potentiates dodecanol's fungicidal activity by reducing PDR5 expression in budding yeast. Fujita KI; Ishikura T; Jono Y; Yamaguchi Y; Ogita A; Kubo I; Tanaka T Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):477-484. PubMed ID: 27632201 [TBL] [Abstract][Full Text] [Related]
53. Vba4p, a vacuolar membrane protein, is involved in the drug resistance and vacuolar morphology of Saccharomyces cerevisiae. Kawano-Kawada M; Pongcharoen P; Kawahara R; Yasuda M; Yamasaki T; Akiyama K; Sekito T; Kakinuma Y Biosci Biotechnol Biochem; 2016; 80(2):279-87. PubMed ID: 26325352 [TBL] [Abstract][Full Text] [Related]
54. Genetic and physiological analysis of azole sensitivity in Saccharomyces cerevisiae. Kenna S; Bligh HF; Watson PF; Kelly SL J Med Vet Mycol; 1989; 27(6):397-406. PubMed ID: 2560793 [TBL] [Abstract][Full Text] [Related]
55. Saccharomyces cerevisiae oesophagitis in a patient with oesophageal carcinoma. Kliemann DA; Antonello VS; Severo LC; Pasqualotto AC J Infect Dev Ctries; 2011 Jul; 5(6):493-5. PubMed ID: 21727651 [TBL] [Abstract][Full Text] [Related]
56. Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase. Billack B; Santoro M; Lau-Cam C Microb Drug Resist; 2009 Jun; 15(2):77-83. PubMed ID: 19432523 [TBL] [Abstract][Full Text] [Related]
57. Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods. Tiballi RN; Spiegel JE; Zarins LT; Kauffman CA Diagn Microbiol Infect Dis; 1995 Dec; 23(4):135-40. PubMed ID: 9407218 [TBL] [Abstract][Full Text] [Related]
58. Yeasts and fluconazole susceptibility in the Philippines. Bulmer GS; Marquez ML; Co-Barcelona L; Fromtling RA Mycopathologia; 1999; 146(3):117-20. PubMed ID: 10823182 [TBL] [Abstract][Full Text] [Related]
59. Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase. Sagatova AA; Keniya MV; Tyndall JDA; Monk BC Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263059 [TBL] [Abstract][Full Text] [Related]
60. Defective sterol C5-6 desaturation and azole resistance: a new hypothesis for the mode of action of azole antifungals. Watson PF; Rose ME; Ellis SW; England H; Kelly SL Biochem Biophys Res Commun; 1989 Nov; 164(3):1170-5. PubMed ID: 2556119 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]